420 Investor Weekly Review 11/25/22

Review

The FDA warned five companies that are illegally selling food and beverage products with CBD. New York issued 36 adult-use retail licenses and will delay the current 10 medical operators from opening adult-use stores. Canadian sales of cannabis were higher than expected in September but flat with August at C$389.9 million, up 12.2% from a year ago.

I distributed this written material to 420 Investor subscribers during the week:

Here are some of this week's highlights for Focus List names:

  • AAWH opened its second medical cannabis dispensary in Pennsylvania. It also announced the departure of a director and the addition of two new ones.
  • CURLF opened two new Florida medical cannabis dispensaries.
  • GRWG opened its 60th store overall in Mount Holly, New Jersey.
  • OGI launched a new value brand, HOLY MOUNTAIN.
  • VFF unit Pure Sunfarms launched Nowadays, a collection of CBD products.

Please check the Focus List, (which has technical, fundamental and valuation ratings as well as a market-cap table). To help track market caps, we maintain tables for the Canadian LPs and the American cannabis operators and ancillary companies.

There were comments in over 90 discussions in the Forum. Don't miss out on this most informative part of 420 Investor! Not familiar with the the Forum? This video will help! This is a great way to track your favorite tickers, even those not on the Focus List, and to get your questions answered quickly.

Market Performance

The Global Cannabis Stock Index remained far above its all-time closing low of 11.26 from 9/30. It rose to 13.37 this Friday, ending unchanged during the week. This was a little worse than the 1.5% gain in ...

Read More
Comments

420 Investor Weekly Review 11/18/22

Review

Michigan cannabis sales in October slipped sequentially by 1.2% but expanded by 28.1% from a year ago to $209.4 million.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 11/11/22

Review

Two of the five states voting to legalize cannabis for adult-use, Maryland and Missouri, passed it, while three others, Arkansas, North Dakota and South Dakota, voted against doing so.

I distributed this written material to 420 Investor subscribers during ...

Read More
Comments

420 Investor Weekly Review 11/04/22

Review

Illinois released both adult-use and medical cannabis data for October, with sales of $160 million, up 0.8% sequentially and 3.1% from a year ago. BDSA data for September suggested that sales remained weak in most markets.

I distributed this ...

Read More
Comments

420 Investor Weekly Review 10/28/22

Review

The big news for the industry this week was the announcement by Canopy Growth regarding its U.S. acquisitions, which opens the door potentially for MSOs to trade on the NASDAQ. Also, Germany appears to be moving forward with its ...

Read More
Comments

420 Investor Weekly Review 10/21/22

Review

Canadian cannabis sales in August rose 0.2% to C$393.7 million. This was up only 13% from a year ago, the slowest annual growth yet. A German plan to legalize for adult-use was leaked.

I distributed this written material to ...

Read More
Comments

420 Investor Weekly Review 10/14/22

Review

Michigan cannabis sales expanded 2% sequentially in September to a record $212 million, up 31.4% from a year ago. Illinois added medical data for September to the previously released adult-use data, and that state saw sales rise 0.2% sequentially ...

Read More
Comments

420 Investor Weekly Review 10/07/22

Review

The big news this week was an unexpected move by President Biden regarding pardoning federal cannabis offenders and to seek rescheduling talks. BDSA data for August showed a small sequential decline across the 11 markets it covers in total. ...

Read More
Comments

420 Investor Weekly Review 09/30/22

Review

There was no important industry news this week.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 09/23/22

Review

Canada is finally reviewing the adult-use program. The country saw sales increase sequentially by 4.5% to C$394.8 million in July, up 17.8% from a year ago.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 09/16/22

Review

Michigan cannabis sales fell 1% sequentially in August due to continued weakness in medical. Sales of $207.9 million, up 26% from a year ago, were supported by a record level of adult-use sales.

I distributed this written material to ...

Read More
Comments

420 Investor Weekly Review 09/09/22

Review

BDSA data for July showed continued modest growth in most of the states that they track sequentially in July. Mature markets in the West fell dramatically from a year ago. Hifyre data suggests that Canadian retail cannabis sales fell ...

Read More
Comments